Introduction
The pharmaceutical trade norms update has introduced a crucial change for exporters. The Directorate General of Foreign Trade (DGFT) has issued a new Standard Input Output Norm (SION) — A-3685 — for Doxycycline 100 mg dispersible tablets. This move is set to streamline raw material procurement and boost Indian pharmaceutical exports.
What is SION A-3685?
The Standard Input Output Norms (SION) specify the input materials and the quantity required to produce one unit of an export product.
The latest addition:
| Item | Details |
|---|---|
| Export Product | Doxycycline 100mg Dispersible Tablets |
| SION Code | A-3685 |
| Notification | Public Notice No. 05/2025, DGFT, dated 24-Apr-2025 |
Key Inputs Permitted:
- Doxycycline Hydrochloride (API grade)
- Excipients like starch, microcrystalline cellulose
- Packaging materials
Important:
Exporters can now claim advance authorization benefits against this specific SION, ensuring faster compliance and predictable input usage norms.
Why This Update Matters for Exporters
- Clear Input-Output Mapping:
No guesswork. Inputs are pre-approved, reducing disputes during advance authorisation scrutiny. - Faster Approvals:
Customs and DGFT authorities can now process authorisations swiftly since SION A-3685 provides predefined material norms. - Cost Efficiency:
Predictable input lists enable bulk procurement planning, reducing production costs for exporters. - Boost to Pharma Exports:
Standardisation aligns Indian pharma with global export expectations, boosting credibility.
Step-by-Step Guide: How to Use New SION A-3685 for Export
- Check Eligibility:
Ensure your product matches the exact description (Doxycycline 100mg dispersible tablet). - Apply for Advance Authorization:
Refer to SION A-3685 norms in your DGFT application. - Maintain Input Records:
Match actual input consumption with allowed quantities under the SION. - Claim Benefits:
Post-export, use the SION reference for duty remission claims or EPCG obligations.